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Importance of Meta-analyses 
for Evaluating Carcinogens 
http://dx.doi.org/10.1289/ehp.1104755
Camargo et al. (2011) published the most 
complete meta-analysis on asbestos and ovar-
ian cancer, concluding that “Our study sup-
ports the IARC [International Agency for 
Research on Cancer] conclusion that expo-
sure to asbestos is associated with increased 
risk of ovarian cancer.” Imagine if it had not! 
The  IARC  Monograph  Working 
Group met in 2009 (Straif et al. 2009), but 
the working group, which included four 
authors of the Carmargo et al. (2011) paper, 
apparently did not make use of a formal meta-
analysis of all available studies to evaluate the 
evidence. Although the IARC Monographs staff 
have occasionally conducted meta-analyses 
prior to a monograph (e.g., Guha et al. 
2009), formal meta-analyses are not prepared 
routinely for the evaluations. However, such 
meta-analyses can be considered when they 
are publicly available and, as stated in the 
“Preamble to the IARC Monographs,” “ad-hoc 
calculations that combine data from different 
studies may be conducted by the Working 
Group during the course of a Monograph 
meeting” (IARC 2012).
Although meta-analyses have been widely 
used in social sciences and medical research 
for decades, it is only recently that they have 
become more widely used in epidemiology 
(Greenland and O’Rourke 2008), and they 
were not widely used at the time that the IARC 
Monograph procedures were first developed. As 
Greenland and O’Rourke (2008) comment, 
Epidemiologic studies of specific topics have 
tended to be fewer [than is the case in social 
science or medicine], and the epidemiologic 
community appears to be more hospitable to 
tentative, limited inferences based on narrative 
reviews. Nonetheless, to neglect quantitative 
aspects of review would be akin to presenting a 
study and supplying only a narrative discussion 
of the raw data, with no attempt to group and 
compare subject outcomes.
Having participated in several Monograph 
Working Groups, we know that informal 
meta-analyses are performed by members 
of the working groups (at least by ourselves) 
because this is one of the standard ways to 
quantitatively summarize the evidence. Meta-
analyses can be challenging and controversial 
depending on assumptions, particularly for 
studies on occupational and environmental 
exposures that frequently are not easy to 
quantify. Certainly meta-analy  ses cannot be 
done for all agents evaluated by IARC, and 
results of meta-analyses have to be critically 
interpreted in a manner similar to that of all 
other data. 
Even without using formal procedures 
for a quantitative summary of the epidemio-
logical evidence, IARC Working Groups 
reach conclusions that are seldom seriously 
challenged, particularly for Group 1 
carcinogens. This is probably because 
IARC Working Groups tend to express the 
consensus in the scientific world. When 
they occasionally have made controversial 
decisions, for example the 1997 dioxin 
evaluation reclassifying TCDD from a 
Group 2B (possible) carcinogen to Group 1, 
they seem to have been proven right by later 
research. IARC has revised procedures for the 
Monographs evalua  tions, incorporating the 
systematic inclusion of biological knowledge 
into the criteria for the classifications, and 
has also updated the whole process for other 
items, such as conflict of interest and the 
prodecure for the selection of participants. 
These changes have strengthened the validity 
and acceptance of these evaluations. Given 
the international importance of the IARC 
Monographs, it seems advisable to use all the 
tools available for summarizing the scientific 
evidence, one of which is meta-analysis. 
The meta-analysis by Camargo et al. (2011) 
clearly demon  strates this regarding both the 
overall meta-estimate that is not negligible 
(standardized mortality ratio of around 1.8) 
and the discussion of the hetero  geneity of the 
findings between studies that can be formally 
examined in a meta-analysis. If we had been 
members of that Working Group, we would 
certainly have preferred to have this meta-
analysis on hand before doing the evaluation.
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Basu et al. (2011) reported the associations of 
both dietary and blood nutrient measures, as 
well as urinary creatinine (uCr), with arsenic 
(As) methyla  tion capacity, as assessed by the 
proportions of urinary inorganic, mono  methyl, 
and dimethyl As metabolites. One finding 
was that uCr was the strongest predictor of 
As methylation; participants with higher 
uCr concentrations had a higher percentage 
of total urinary As as dimethylarsinic acid 
(DMA) compared to those with lower 
uCr. This is consistent with what we have 
previously reported in Bangladeshi adults and 
children (Gamble et al. 2005; Ahsan et al. 
2007; Hall et al. 2009), and is an interesting 
and potentially very important observation. 
Approximately 40% of S-adenosylmethionine 
(SAM)-derived methyl groups are devoted to 
the bio  synthesis of creatine, the precursor of 
creati  nine (Brosnan et al. 2011; Mudd and 
Poole 1975). At high levels of As exposure 
(500–1,000 µg/L), based on one-carbon 
kinetics (Schalinske and Steele 1989), we 
estimated that methyla  tion of 80% of a daily 
dose of inorganic As (InAs) to DMA would 
require approximately 50 µmol SAM, thus 
consuming approximately 2–4% of the SAM 
normally turning over in a well-nourished 
adult per day. Low dietary crea  tine intake 
associated with low-protein or vegetarian diets 
places an increased demand for SAM for crea-
tine biosynthesis (Brosnan 2011). This could 
potentially reduce the availability of SAM for 
As methylation, providing a plausible mecha-
nism under  lying this highly reproducible 
observation. This assumes that uCr reflects, 
to some extent, dietary creatine intake, as 
we have observed (Gamble M, unpublished 
data). Conversely, dietary crea  tine intake 
and/or creatine supplementation down-
regulates endogenous creatine bio  synthesis, 
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potentially sparing SAM for methyla  tion of 
other substrates such as As. We are currently 
testing this hypothesis in a randomized 
controlled trial of creatine supplementation. 
In addition, as Basu et al. (2011) noted, and 
as we have previously reported (Gamble and 
Liu 2005), one implication of the observed 
association between uCr and As methylation 
capacity is that urinary As should not be 
expressed per gram creatinine to correct for 
urine concentration. Rather, uCr should be 
included as a covariate in regression models. 
One concerning aspect of the study by 
Basu et al. (2011) is the handling of blood 
samples used for nutrient measure  ments. As 
noted by Basu et al. and in a previous pub-
lication on these same participants (Chung 
et al. 2006), the blood samples were stored 
in an ice chest in the field for up to 24 hr 
before processing. This 24-hr delay can be 
problematic for some nutrients, especially 
folate, which is extremely sensitive to oxida-
tive degrada  tion (Drammeh et al. 2008). Basu 
et al. (2011) reported that in uni  variate analy-
ses, they observed higher urinary percentages 
of InAs in individuals with higher serum 
folate concentrations. This finding is contrary 
to our previous findings that folate facilitates 
As methylation (Gamble et al. 2005, 2006, 
2007; Hall et al. 2007, 2009). This discrep-
ancy might be explained by differences in 
sample processing. 
Basu et al. (2011) also reported associa-
tions between dietary intake of several nutri-
ents (assessed using a modified 24-hr recall) 
and As methylation capacity. One of the most 
critical and widely discussed issues in nutri-
tional epidemiology is the method used to 
adjust for total energy intake (TEI) (Willett 
et al. 1997). The main reasons to adjust for 
TEI are to a) adjust for potential confound-
ing by TEI, b) remove extraneous variation 
in nutrient intakes that is due only to their 
correlation with TEI, and c) simulate a dietary 
intervention. What is often most relevant is 
diet composition, or nutrient intake in rela-
tion to TEI (Willett et al. 1997). Several 
methods are available to adjust for TEI, and 
the best approach can vary depending on 
the nutrient and question of interest. Basu 
et al. (2011) adjusted for TEI by dividing 
each nutrient intake by TEI (nutrient density 
method). While this approach is appealing 
because of its simplicity, in reality it can cre-
ate a complex variable (Willett and Stampfer 
1998). For example, when TEI is related 
to the outcome of interest, the use of nutri-
ent densities can actually induce confound-
ing in the opposite direction. Although we 
cannot determine from Basu et al.’s article 
whether TEI measured by the 24-hr recall 
was associated with As methylation, in theory, 
an association seems plausible. Also, because 
their statistical analy  sis tested for associations 
between multiple nutrients and urinary As 
metabolites, it is best to acknowledge that 
some of the statistically significant associations 
might be due to chance alone.
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We thank Hall and Gamble for their interest 
in our findings. In our article (Basu et al. 
2011), we cited their earlier results concerning 
urinary dimethylarsinic acid (DMA) and 
creati  nine concentrations, noting that in 2005 
they reported a strong correlation between 
urinary creatinine and the percentage of DMA 
(DMA%) (Gamble et al. 2005). We also 
noted rather similar findings from another 
group working in Bangladesh (Nermell et al. 
2008), so together with our findings in India, 
there are three separate studies that have 
reported this association (Basu et al. 2011; 
Gamble et al 2005; Nermell et al 2008). 
Our results highlight the strength of the 
relation  ship between urinary creatinine and 
urinary DMA%, which was stronger than 
the relationship between DMA% and any of 
the 19 dietary factors and 16 blood micro-
nutrients that we investigated.
Gamble and Hall state that they had pre-
viously reported (Gamble and Liu 2005) 
that one implication of the observed asso-
ciation between urinary creatinine and arse-
nic methyla  tion was that urinary As should 
not be expressed as per gram creatinine to 
correct for urine concentrations. This is 
not quite what they said, although they did 
point out risks in expressing urinary arsenic 
per gram of creatinine. However, in that 
letter (Gamble and Liu 2005) and again in 
this one, they state that urinary creatinine 
should be included as a covariate in regres-
sion models. We do not agree with this 
recom  mendation. Steinmaus et al. (2009) 
reported a spurious relation  ship between 
low-level arsenic concentrations and diabetes 
in the United States after including urinary 
creatinine in a regression model. They noted 
that urinary creatinine concentrations may 
change as a consequence of diabetes, which 
is known to affect renal function, and that it 
is not appropriate to adjust for a factor that 
is a consequence of the disease being studied. 
We also do not agree with Gamble and 
Hall’s criticism of our blood sample handling, 
which they appear to have raised because our 
folate findings were different from theirs (e.g., 
Gamble et al. 2005). For our study (Basu 
et al. 2011), blood samples were collected in 
remote villages, and on occasion they had to 
be stored on ice for up to 24 hr. Gamble and 
Hall state that “this 24-hr delay can be prob-
lematic for some nutrients, especially folate, 
which is extremely sensitive to oxidative 
degradation.” In support of this statement 
they cite Drammeh et al. (2008), who found 
reductions in serum folate concentrations 